Cargando…

The Application of Artificial Intelligence-Assisted Colposcopy in a Tertiary Care Hospital within a Cervical Pathology Diagnostic Unit

The rising global incidence of cervical cancer is estimated to have affected more than 600,000 women, and nearly 350,000 women are predicted to have died from the disease in 2020 alone. Novel advances in cancer prevention, screening, diagnosis and treatment have all but reduced the burden of cervica...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmer-Stelmach, Aleksandra, Zak, Jan, Pawlosek, Agata, Rosner-Tenerowicz, Anna, Budny-Winska, Joanna, Pomorski, Michal, Fuchs, Tomasz, Zimmer, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774766/
https://www.ncbi.nlm.nih.gov/pubmed/35054273
http://dx.doi.org/10.3390/diagnostics12010106
_version_ 1784636425274130432
author Zimmer-Stelmach, Aleksandra
Zak, Jan
Pawlosek, Agata
Rosner-Tenerowicz, Anna
Budny-Winska, Joanna
Pomorski, Michal
Fuchs, Tomasz
Zimmer, Mariusz
author_facet Zimmer-Stelmach, Aleksandra
Zak, Jan
Pawlosek, Agata
Rosner-Tenerowicz, Anna
Budny-Winska, Joanna
Pomorski, Michal
Fuchs, Tomasz
Zimmer, Mariusz
author_sort Zimmer-Stelmach, Aleksandra
collection PubMed
description The rising global incidence of cervical cancer is estimated to have affected more than 600,000 women, and nearly 350,000 women are predicted to have died from the disease in 2020 alone. Novel advances in cancer prevention, screening, diagnosis and treatment have all but reduced the burden of cervical cancer in developed nations. Unfortunately, cervical cancer is still the number one gynecological cancer globally. A limiting factor in managing cervical cancer globally is access to healthcare systems and trained medical personnel. Any methodology or procedure that may simplify or assist cervical cancer screening is desirable. Herein, we assess the use of artificial intelligence (AI)-assisted colposcopy in a tertiary hospital cervical diagnostic pathology unit. The study group consisted of 48 women (mean age 34) who were referred to the clinic for a routine colposcopy by their gynecologist. Cervical images were taken by an EVA-Visualcheck (TM) colposcope and run through an AI algorithm that gave real-time binary results of the cervical images as being either normal or abnormal. The primary endpoint of the study assessed the AI algorithm’s ability to correctly identify histopathology results of CIN2+ as being abnormal. A secondary endpoint was a comparison between the AI algorithm and the clinical assessment results. Overall, we saw lower sensitivity of AI (66.7%; 12/18) compared with the clinical assessment (100%; 18/18), and histopathology results as the gold standard. The positive predictive value (PPV) was comparable between AI (42.9%; 12/28) and the clinical assessment (41.8%; 18/43). The specificity, however, was higher in the AI algorithm (46.7%; 14/30) compared to the clinical assessment (16.7%; 5/30). Comparing the congruence between the AI algorithm and histopathology results showed agreement 54.2% of the time and disagreement 45.8% of the time. A trained colposcopist was in agreement 47.9% and disagreement 52.1% of the time. Assessing these results, there is currently no added benefit of using the AI algorithm as a tool of speeding up diagnosis. However, given the steady improvements in the AI field, we believe that AI-assisted colposcopy may be of use in the future.
format Online
Article
Text
id pubmed-8774766
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87747662022-01-21 The Application of Artificial Intelligence-Assisted Colposcopy in a Tertiary Care Hospital within a Cervical Pathology Diagnostic Unit Zimmer-Stelmach, Aleksandra Zak, Jan Pawlosek, Agata Rosner-Tenerowicz, Anna Budny-Winska, Joanna Pomorski, Michal Fuchs, Tomasz Zimmer, Mariusz Diagnostics (Basel) Article The rising global incidence of cervical cancer is estimated to have affected more than 600,000 women, and nearly 350,000 women are predicted to have died from the disease in 2020 alone. Novel advances in cancer prevention, screening, diagnosis and treatment have all but reduced the burden of cervical cancer in developed nations. Unfortunately, cervical cancer is still the number one gynecological cancer globally. A limiting factor in managing cervical cancer globally is access to healthcare systems and trained medical personnel. Any methodology or procedure that may simplify or assist cervical cancer screening is desirable. Herein, we assess the use of artificial intelligence (AI)-assisted colposcopy in a tertiary hospital cervical diagnostic pathology unit. The study group consisted of 48 women (mean age 34) who were referred to the clinic for a routine colposcopy by their gynecologist. Cervical images were taken by an EVA-Visualcheck (TM) colposcope and run through an AI algorithm that gave real-time binary results of the cervical images as being either normal or abnormal. The primary endpoint of the study assessed the AI algorithm’s ability to correctly identify histopathology results of CIN2+ as being abnormal. A secondary endpoint was a comparison between the AI algorithm and the clinical assessment results. Overall, we saw lower sensitivity of AI (66.7%; 12/18) compared with the clinical assessment (100%; 18/18), and histopathology results as the gold standard. The positive predictive value (PPV) was comparable between AI (42.9%; 12/28) and the clinical assessment (41.8%; 18/43). The specificity, however, was higher in the AI algorithm (46.7%; 14/30) compared to the clinical assessment (16.7%; 5/30). Comparing the congruence between the AI algorithm and histopathology results showed agreement 54.2% of the time and disagreement 45.8% of the time. A trained colposcopist was in agreement 47.9% and disagreement 52.1% of the time. Assessing these results, there is currently no added benefit of using the AI algorithm as a tool of speeding up diagnosis. However, given the steady improvements in the AI field, we believe that AI-assisted colposcopy may be of use in the future. MDPI 2022-01-04 /pmc/articles/PMC8774766/ /pubmed/35054273 http://dx.doi.org/10.3390/diagnostics12010106 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zimmer-Stelmach, Aleksandra
Zak, Jan
Pawlosek, Agata
Rosner-Tenerowicz, Anna
Budny-Winska, Joanna
Pomorski, Michal
Fuchs, Tomasz
Zimmer, Mariusz
The Application of Artificial Intelligence-Assisted Colposcopy in a Tertiary Care Hospital within a Cervical Pathology Diagnostic Unit
title The Application of Artificial Intelligence-Assisted Colposcopy in a Tertiary Care Hospital within a Cervical Pathology Diagnostic Unit
title_full The Application of Artificial Intelligence-Assisted Colposcopy in a Tertiary Care Hospital within a Cervical Pathology Diagnostic Unit
title_fullStr The Application of Artificial Intelligence-Assisted Colposcopy in a Tertiary Care Hospital within a Cervical Pathology Diagnostic Unit
title_full_unstemmed The Application of Artificial Intelligence-Assisted Colposcopy in a Tertiary Care Hospital within a Cervical Pathology Diagnostic Unit
title_short The Application of Artificial Intelligence-Assisted Colposcopy in a Tertiary Care Hospital within a Cervical Pathology Diagnostic Unit
title_sort application of artificial intelligence-assisted colposcopy in a tertiary care hospital within a cervical pathology diagnostic unit
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774766/
https://www.ncbi.nlm.nih.gov/pubmed/35054273
http://dx.doi.org/10.3390/diagnostics12010106
work_keys_str_mv AT zimmerstelmachaleksandra theapplicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT zakjan theapplicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT pawlosekagata theapplicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT rosnertenerowiczanna theapplicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT budnywinskajoanna theapplicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT pomorskimichal theapplicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT fuchstomasz theapplicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT zimmermariusz theapplicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT zimmerstelmachaleksandra applicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT zakjan applicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT pawlosekagata applicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT rosnertenerowiczanna applicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT budnywinskajoanna applicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT pomorskimichal applicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT fuchstomasz applicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit
AT zimmermariusz applicationofartificialintelligenceassistedcolposcopyinatertiarycarehospitalwithinacervicalpathologydiagnosticunit